C19, a C-terminal peptide of chemokine-like factor 1, protects the brain against focal brain ischemia in rats

Neuroscience Letters

Volumn 508, Issue 1, 2012, Pages 13-16

  Kong, Ling Lei ^a   Hu, Jin Feng ^a   Zhang, Wei ^a   Yuan, Yu He ^a   Han, Ning ^a   Chen, Nai Hong ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

C19 peptide; Cerebral ischemia; Chemokine like factor 1; Rats

Indexed keywords

C19; CHEMOKINE; CHLORAL HYDRATE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; MALE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; REPERFUSION; WATER CONTENT;

ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; MALE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84855959786     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.11.048     Document Type: Article

References (23)

1. Banisadr G., Rostène W., Kitabgi P., Parsadaniantz S.M. Chemokines and brain functions. Curr. Drug Targets Inflamm. Allergy 2005, 4:387-399.
2. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Rev. 2005, 48:16-42.
3. Chen Y., Hallenbeck J.M., Ruetzler C., Bol D., Thomas K., Berman N.E., Vogel S.N. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J. Cereb. Blood Flow Metab. 2003, 23:748-755.
4. Dimitrijevic O.B., Stamatovic S.M., Keep R.F., Andjelkovic A.V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007, 38:1345-1353.
5. Frevert C.W., Huang S., Danaee H., Paulauskis J.D., Kobzik L. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J. Immunol. 1995, 154:335-344.
6. Feng L., Xia Y., Yoshimura T., Wilson C.B. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Invest. 1995, 95:1009-1017.
7. Gale L.M., McColl S.R. Chemokines: extracellular messengers for all occasions. Bioessays 1999, 21:17-28.
8. Hughes P.M., Allegrini P.R., Rudin M., Perry V.H., Mir A.K., Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 2002, 22:308-317.
9. Han W., Lou Y., Tang J., Zhang Y., Chen Y., Li Y., Gu W., Huang J., Gui L., Tang Y., Li F., Song Q., Di C., Wang L., Shi Q., Sun R., Xia D., Rui M., Tang J., Ma D. Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem. J. 2001, 357:127-135.
10. Kong L.L., Hu J.F., Zhang W., Yuan Y.H., Ma K.L., Han N., Chen N.H. Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat. Neurosci. Lett. 2011, 505:14-18.
11. Kumai Y., Ooboshi H., Takada J., Kamouchi M., Kitazono T., Egashira K., Ibayashi S., Iida M. Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats. J. Cereb. Blood Flow Metab. 2004, 24:1359-1368.
12. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
13. Mennicken F., Maki R., de Souza E.B., Quirion R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 1999, 20:73-78.
14. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2002, 2:106-115.
15. Soriano S.G., Amaravadi L.S., Wang Y.F., Zhou H., Yu G.X., Tonra J.R. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 2002, 125:59-65.
16. Tian L., Li W., Wang J., Zhang Y., Zheng Y., Qi H., Guo X., Zhang Y., Ma D., Shen H., Wang Y. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma. Allergy 2011, 66:287-297.
17. Takami S., Minami M., Katayama T., Nagata I., Namura S., Satoh M. TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2002, 22:780-784.
18. Takami S., Minami M., Nagata I., Namura S., Satoh M. Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2001, 21:1430-1435.
19. Tan Y.X., Han W.L., Chen Y.Y., Ouyang N.T., Tang Y., Li F., Ding P.G., Ren X.L., Zeng G.Q., Ding J., Zhu T., Ma D.L., Zhong N.S. Chemokine-like factor 1, a novel cytokine, contributes to airway damage, remodeling and pulmonary fibrosis. Chin. Med. J. (Engl.) 2004, 117:1123-1129.
20. Wells T.N., Power C.A., Shaw J.P., Proudfoot A.E. Chemokine blockers-therapeutics in the making. Trends Pharmacol. Sci. 2006, 27:41-47.
21. Wang Y., Zhang Y., Han W., Li D., Tian L., Yin C., Ma D. Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4. Int. J. Biochem. Cell Biol. 2008, 40:909-919.
22. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
23. Zhang Y., Tian L., Zheng Y., Qi H., Guo C., Sun Q., Xu E., Zhang Y., Ma D., Wang Y. C-terminal peptides of chemokine-like factor 1 signal through chemokine receptor CCR4 to cross-desensitize the CXCR4. Biochem. Biophys. Res. Commun. 2011, 409:356-361.